BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Jul 18, 2025

BHIC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
2.791.840.60.07-
Revenue Growth (YoY)
231.54%208.73%761.80%--
Cost of Revenue
0.820.540.110.01-
Gross Profit
1.971.310.480.06-
Selling, General & Admin
1.41.220.740.170.01
Operating Expenses
1.41.220.740.170.01
Operating Income
0.570.09-0.25-0.11-0.01
Other Non Operating Income (Expenses)
----0.06-
Pretax Income
0.570.09-0.25-0.17-0.01
Net Income
0.570.09-0.25-0.17-0.01
Net Income to Common
0.570.09-0.25-0.17-0.01
Shares Outstanding (Basic)
43423483
Shares Outstanding (Diluted)
43423483
Shares Change (YoY)
6.01%25.44%301.99%147.38%-
EPS (Basic)
0.010.00-0.01-0.02-0.00
EPS (Diluted)
0.010.00-0.01-0.02-0.00
Gross Margin
70.51%70.94%81.06%86.01%-
Operating Margin
20.30%4.72%-42.09%-161.99%-
Profit Margin
20.30%4.72%-42.09%-245.81%-
EBIT
0.570.09-0.25-0.11-0.01
EBIT Margin
20.30%4.72%-42.09%-161.99%-
Advertising Expenses
-0.130.11--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.